Efforia

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Efforia sits in the top decile of US sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count).

19 total trials 17 currently recruiting 1 completed early-phase tilt top decile by trial count

Efforia: 19 sponsored US clinical trials, 17 recruiting.

Efforia sponsors 19 registered US clinical trials on ClinicalTrials.gov, 17 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sleep, with 4 trials.

Top-decile sponsor footprint

Efforia ranks in the top decile of sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

19 total, page 1 of 1

RECRUITING NA

Beef Versus Whey Protein: The Gut Showdown Self-Experiment

NCT07477223

RECRUITING NA

MyVitalC: Sleep and Everyday Headache Management

NCT07477236

RECRUITING NA

30 Day Insulin Balance Metabolic Health Optimization Protocol

NCT07478497

RECRUITING NA

How Does Continued Use of Green Light Therapy Impact Outcomes?

NCT07282275

RECRUITING NA

Evaluating Heart & Soil's Whole Package on Men's Health

NCT07256639

RECRUITING NA

See the Impact Beem's Blue Light Therapy Has on Your Skin Health!

NCT07298382

RECRUITING NA

Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)

NCT07298369

RECRUITING NA

Chilipad Sleep Optimization Study

NCT07281963

RECRUITING

Pornography Abstinence and Nocturnal Erections in Adult Men

NCT07618104

RECRUITING NA

The Effects on Sleep Quality of 1:4 Reishi Liquid Extract

NCT07294482

RECRUITING NA

Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement

NCT07442864

RECRUITING NA

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels

NCT07293117

RECRUITING NA

Can EmeraldLED Reshape Your Body With Continued Use?

NCT07282119

RECRUITING NA

Sound Stops Stress Study: Evaluating the WAVwatch Effect

NCT07281989

RECRUITING NA

Evaluating SleepWhale Drops for Rest & Resilience

NCT07298161

RECRUITING NA

How Does YES Bar Affect Blood Glucose Levels?

NCT07256652

RECRUITING NA

Discover Better Body Composition With Green Light!

NCT07282080

COMPLETED NA

The Cracking Consciousness Study With Monroe & Neuphoria

NCT07256665

NOT YET RECRUITING Phase 1

Natural Heart Health Supplement Trial

NCT06671769

Phase Distribution

PhaseTrial count
Phase 1 1

What is open in the Efforia pipeline

17 recruiting of 19 indexed (89% open); 1 completed (5%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Sleep (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Efforia: open-pipeline peers nationwide

Peers matched on 19 registered trials and 89% open enrollment, not the therapeutic-area sidebar.

Efforia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 5101520 0%20%40%60%80%100% Total trials Recruiting share EfforiaAlmirall, S.A.Bastyr UniversityChurch & Dwight CompanyCordis USDualityBioOttawa Heart Institute Research CorporationJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyJohnson & Johnson Enterprise Innovation
Efforia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Efforia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 19 trials (± recruiting share)

Sponsors near 89% open enrollment (± trial volume)

What to do with this Efforia page

19 registered trials is a research-attention snapshot, not an endorsement of Efforia or any single study.

  • 17 of Efforia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Sleep is the condition Efforia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sleep trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Efforia pipeline card: 19 registered trials from official public datasets.Report a data error.